Bacterial Infections  >>  Xifaxan (rifaximin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health
VARIANT, NCT02376972: Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis

Terminated
2
392
US
RIFAXIMIN VAGINAL TABLET 25 MG, RIFAXIMIN VAGINAL TABLET 100 MG, PLACEBO VAGINAL TABLET, METROGEL VAGINAL
Alfasigma S.p.A., Parexel
BACTERIAL VAGINOSIS
02/16
02/16

Download Options